ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,970Medicare Part D Prescriptions Filled, Including Refills

Rank: 26 out of 1677

$1.31M Total Retail Price of All Prescriptions

Rank: 26 out of 1677

886 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 886 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

23% of this provider’s 886 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 20,088 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 972 764 1 1
HYDROCODONE-ACETAMINOPHEN 964 679 S3 2 4
AMLODIPINE BESYLATE 920 791 3 2
LISINOPRIL 875 681 4 3
LEVOTHYROXINE SODIUM 841 678 5 5
OMEPRAZOLE 803 620 6 6
HYDROCHLOROTHIAZIDE 700 608 7 9
FUROSEMIDE 669 568 8 8
METFORMIN HCL 493 381 9 7
CITALOPRAM HBR 429 332 10 22
METOPROLOL TARTRATE 425 360 11 12
GABAPENTIN 350 227 12 11
CARVEDILOL 347 258 13 20
ALLOPURINOL 324 264 14 31
METOPROLOL SUCCINATE 317 246 15 23
TRAMADOL HCL 312 216 16 16
POTASSIUM CHLORIDE 312 278 16 14
MELOXICAM 272 204 18 27
ATENOLOL 271 221 19 21
NEXIUM 266 137 20 19
ATORVASTATIN CALCIUM 260 223 21 13
RANITIDINE HCL 257 186 22 18
ZOLPIDEM TARTRATE 253 214 23 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 240 156 24 17
GLIMEPIRIDE 232 157 25 33
DIOVAN 222 214 26 45
WARFARIN SODIUM 219 199 27 24
POLYETHYLENE GLYCOL 3350 218 187 28 76
CLOPIDOGREL 218 169 28 32
MIRTAZAPINE 210 176 30 62
PRAVASTATIN SODIUM 206 147 31 10
LOSARTAN POTASSIUM 203 201 32 25
ROPINIROLE HCL 201 125 33 79
DONEPEZIL HCL 185 185 34 30
CRESTOR 182 144 35 28
TAMSULOSIN HCL 170 144 36 34
CYCLOBENZAPRINE HCL 167 106 R 37 52
CYMBALTA 166 134 38 58
NAMENDA 163 156 39 39
TRAZODONE HCL 162 107 40 37
ALENDRONATE SODIUM 161 135 41 43
PLAVIX 157 125 42 47
HYDRALAZINE HCL 151 135 43 69
AZITHROMYCIN 146 106 44 38
FLUTICASONE PROPIONATE 140 105 45 29
SPIRIVA 139 90 46 74
LYRICA 139 91 46 81
LANTUS 134 97 48 44
SERTRALINE HCL 133 80 49 26
CIPROFLOXACIN HCL 131 108 50 57
DIGOXIN 123 123 51 71
AMOXICILLIN 122 66 52 94
CLONIDINE HCL 120 106 53 36
LOSARTAN-HYDROCHLOROTHIAZIDE 114 96 54 42
FENOFIBRATE 113 99 55 48
ADVAIR DISKUS 113 78 55 54
MECLIZINE HCL 113 101 55 110
PREDNISONE 111 103 58 40
LIPITOR 105 87 59 101
PROMETHAZINE HCL 100 54 R 60 64
TRIAMTERENE-HCTZ 97 50 61 61
PANTOPRAZOLE SODIUM 96 87 62 46
JANUVIA 95 55 63 70
TRICOR 95 50 63 100
AMLODIPINE BESYLATE-BENAZEPRIL 94 57 65 59
BUSPIRONE HCL 89 44 66 120
FLUCONAZOLE 89 58 66 127
ENALAPRIL MALEATE 89 59 66 82
LOVASTATIN 88 70 69 35
ACTOS 86 74 70 104
PROAIR HFA 84 51 71 50
PAROXETINE HCL 80 73 72 67
RISPERIDONE 79 52 73 60
METOCLOPRAMIDE HCL 79 49 73 124
FLUOXETINE HCL 79 61 73 49
OXYCODONE-ACETAMINOPHEN 76 67 S2 76 122
QUETIAPINE FUMARATE 75 41 77 77
ESCITALOPRAM OXALATE 72 62 78 80
OXYBUTYNIN CHLORIDE ER 72 60 78 173
INSULIN SYRINGE 72 44 78 72
ESTRADIOL 70 52 R 81 129
CARBIDOPA-LEVODOPA 69 65 82 131
NOVOLIN R 69 55 82 133
LANSOPRAZOLE 68 42 84 147
ALBUTEROL SULFATE 68 68 84 135
THEOPHYLLINE ANHYDROUS 66 53 86 250
BENICAR 63 60 87 178
LEVOFLOXACIN 63 51 87 84
FELODIPINE ER 63 52 87 193
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 55 90 85
FENTANYL 61 50 S2 91 103
DILTIAZEM ER 61 52 91 143
MORPHINE SULFATE ER 59 29 S2 93 140
DIVALPROEX SODIUM 59 52 93 111
DILTIAZEM 24HR CD 57 57 95 156
METFORMIN HCL ER 57 47 95 51
COMBIVENT 57 17 95 105
CLOTRIMAZOLE-BETAMETHASONE 57 50 95 166
NOVOLOG 56 43 99 117
DIOVAN HCT 56 28 99 66
LIDODERM 55 46 101 160
DETROL LA 54 36 102 185
PRAMIPEXOLE DIHYDROCHLORIDE 54 41 102 172
VENTOLIN HFA 53 42 104 89
ACETAMINOPHEN-CODEINE 53 37 S3 104 136
CELEBREX 53 32 104 102
GLIPIZIDE 52 29 107 56
HYDROXYZINE HCL 52 46 R 107 148
LEVEMIR 50 17 109 157
TERAZOSIN HCL 50 49 109 138
SPIRONOLACTONE 50 48 109 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.